Shivakumar Keerthikumar

Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

Variable cellular and radiobiological effects of [177Lu]Lu-PSMA-I&T in patient-derived models of prostate cancer.

Variable cellular and radiobiological effects of [177Lu]Lu-PSMA-I&T in patient-derived models of prostate cancer.

Journal: Journal of experimental & clinical cancer research : CR
Published: November 26, 2025

Single-Cell Morphomechanics of Prostate Cancer-Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome.

Single-Cell Morphomechanics of Prostate Cancer-Associated Fibroblasts Identifies Distinct Features Associated with Patient Outcome.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: November 06, 2025

Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.

Single-cell transcriptomics redefines focal neuroendocrine differentiation as a distinct prostate cancer pathology.

Journal: Molecular oncology
Published: March 20, 2025

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.

Reprogramming of Androgen Receptor Activity in Castration-resistant Prostate Cancer is Shaped by Truncated Variants.

Journal: European urology focus
Published: February 02, 2025

p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.

p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: November 25, 2024

Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.

Co-targeting BET, CBP, and p300 inhibits neuroendocrine signalling in androgen receptor-null prostate cancer.

Journal: The Journal of pathology
Published: October 05, 2023

Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer.

Multi-substrate Metabolic Tracing Reveals Marked Heterogeneity and Dependency on Fatty Acid Metabolism in Human Prostate Cancer.

Journal: Molecular cancer research : MCR
Published: November 03, 2022

Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.

Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human prostate cancer models.

Journal: Nature communications
Published: September 06, 2022

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.

Mast Cell-Derived SAMD14 Is a Novel Regulator of the Human Prostate Tumor Microenvironment.

Journal: Cancers
Published: February 18, 2021

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

The MURAL collection of prostate cancer patient-derived xenografts enables discovery through preclinical models of uro-oncology.

Journal: Nature communications
Published: February 15, 2021

Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.

Analytical validation of an error-corrected ultra-sensitive ctDNA next-generation sequencing assay.

Journal: BioTechniques
Published: July 14, 2020

CRISP3 expression drives prostate cancer invasion and progression.

CRISP3 expression drives prostate cancer invasion and progression.

Journal: Endocrine-related cancer
Published: April 28, 2020
Showing 1-12 of 42

Last Updated: 09/26/2026